$ALT
Altimmune, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$3.25
▲+0.31%+$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAltimmune, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ALT up today? It is at $3.25 (+0.31%), and our scanner flagged it 119 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ALT spikes, and full due diligence on ALT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ALT 119 times in the last 30 days. Create a free account to track $ALT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ALT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ALT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Durso Jerome Benedict Officer | Bought (open market) | +15K | added 32% | 63K | $44K at $2.95 | Aug 13, 26 |
Roberts M Scot Officer | Acquired (grant/award) | +875 | added 0.8% | 114K | $2K at $2.41 | Jul 31, 26 |
Weaver Gregory L Officer | Acquired (grant/award) | +2K | added 4.6% | 40K | $4K at $2.41 | Jul 31, 26 |
Gill John Director | Bought (open market) | +9K | added 74% | 22K | $31K at $3.41 | Apr 6, 26 |
Durso Jerome Benedict Officer | Bought (open market) | +15K | added 46% | 48K | $47K at $3.14 | Apr 1, 26 |
Weaver Gregory L Officer | Bought (open market) | +10K | added 36% | 38K | $32K at $3.15 | Apr 1, 26 |
Durso Jerome Benedict Officer | Bought (open market) | +20K 0.01% of company | added 100% | 33K | $71K at $3.54 | Mar 6, 26 |
Weaver Gregory L Officer | Bought (open market) | +5K | added 22% | 28K | $18K at $3.54 | Mar 6, 26 |
Roberts M Scot Officer | Sold (automatic/other) | -2K | sold 2.0% | 113K | $13K at $5.55 | Feb 2, 26 |
Roberts M Scot Officer | Other | 8K | added 7.2% | 115K | n/a | Feb 2, 26 |
Jordt Raymond M Officer | Acquired (grant/award) | +5K | added 7.0% | 70K | $14K at $3.07 | Jan 31, 26 |
Garg Vipin K Director | Acquired (grant/award) | +7K | added 1.7% | 425K | $21K at $3.07 | Jan 31, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ALT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ALT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ALT last traded at $3.25, up 0.31% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Altimmune, Inc. Common Stock (ALT) is next expected to report earnings on Thursday, November 5, 2026, about 48 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ALT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ALT 119 times in the last 30 days.
ALT (Altimmune, Inc. Common Stock) trades on XNAS, with a market cap of about $630M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ALT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ALT discussion
Sign in to ask a question or join the discussion.